Literature DB >> 30950975

Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.

Inês F Gonçalves1, Eylem Acar1, Sarah Costantino2, Petra L Szabo1, Ouafa Hamza1, Eva V Tretter3, Klaus U Klein3, Sandra Trojanek4, Dietmar Abraham4, Francesco Paneni5, Seth Hallström6, Attila Kiss1, Bruno K Podesser1.   

Abstract

BACKGROUND: Tenascin C (TN-C) is considered to play a pathophysiological role in maladaptive left ventricular remodeling. Yet, the mechanism underlying TN-C-dependent cardiac dysfunction remains elusive.
METHOD: The present study was designed to investigate the effect of hypoxia and hypertrophic stimuli on TN-C expression in H9c2 cells and its putative regulation by epigenetic mechanisms, namely DNA promoter methylation and microRNAs. In addition, rats subjected to myocardial infarction (MI) were investigated. H9c2 cells were subjected to oxygen and glucose deprivation; incubated with angiotensin II (Ang II); or human TN-C (hTN-C) purified protein. Hypertrophic and fibrotic markers, TN-C promoter methylation as well as mir-335 expression were assessed by reverse transcription and quantitative polymerase chain reaction while TN-C protein levels were assessed by ELISA.
RESULTS: Tn-C mRNA expression was markedly increased by both oxygen and glucose deprivation and Ang II (P < 0.01, respectively). In addition, Ang-II-dependent TN-C upregulation was explained by reduced promoter methylation (P < 0.05). Cells treated with hTN-C displayed upregulation of Bnp, Mmp2, β-Mhc, integrin α6 and integrin β1. Furthermore, hTN-C treated cells showed a significant reduction in adenosine monophosphate and adenosine triphosphate levels. In vivo, plasma and myocardial TN-C levels were increased 7 days post MI (P < 0.05, respectively). This increment in TN-C was accompanied by upregulation of mir-335 (P < 0.01). In conclusion, both hypoxic and hypertrophic stimuli lead to epigenetically driven TN-C upregulation and subsequent impairment of cellular energy metabolism in cardiomyoblasts.
CONCLUSION: These findings might enlighten our understanding on maladaptive left ventricular remodeling and direct towards a strong involvement of TN-C.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30950975     DOI: 10.1097/HJH.0000000000002097

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Influence of the microenvironment dynamics on extracellular matrix evolution under hypoxic ischemic conditions in the myocardium.

Authors:  Zenaida Ceauşu; Manuela Popa; Bogdan Socea; Gabriel Petre Gorecki; Mariana Costache; Mihai Ceauşu
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

2.  Tenascin C is dysregulated in hypoplastic lungs of miR-200b-/- mice.

Authors:  Moritz Markel; Wai Hei Tse; Nolan DeLeon; Daywin Patel; Shana Kahnamouizadeh; Martin Lacher; Richard Wagner; Richard Keijzer
Journal:  Pediatr Surg Int       Date:  2022-03-02       Impact factor: 1.827

3.  Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction.

Authors:  Bernhard Wernly; Vera Paar; Achim Aigner; Patrick M Pilz; Bruno K Podesser; Martin Förster; Christian Jung; Josefina Pinon Hofbauer; Birgit Tockner; Monika Wimmer; Theo Kraus; Lukas J Motloch; Matthias Hackl; Uta C Hoppe; Attila Kiss; Michael Lichtenauer
Journal:  Cells       Date:  2020-01-25       Impact factor: 6.600

4.  Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice.

Authors:  David Santer; Felix Nagel; Inês Fonseca Gonçalves; Christoph Kaun; Johann Wojta; Miklós Fagyas; Martin Krššák; Ágnes Balogh; Zoltán Papp; Attila Tóth; Viktor Bánhegyi; Karola Trescher; Attila Kiss; Bruno K Podesser
Journal:  ESC Heart Fail       Date:  2020-07-08

5.  Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Mari Hara; Hiromitsu Saito; Noboru Suzuki; Satoshi Sakai; Taizo Kimura; Akira Sato; Akiyo Sekimoto; Satoshi Fujita; Ryuji Okamoto; Robert J Schwartz; Toshimichi Yoshida; Kyoko Imanaka-Yoshida
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

6.  The Role of Tenascin C in Cardiac Reverse Remodeling Following Banding-Debanding of the Ascending Aorta.

Authors:  Mireia Perera-Gonzalez; Attila Kiss; Philipp Kaiser; Michael Holzweber; Felix Nagel; Simon Watzinger; Eylem Acar; Petra Lujza Szabo; Inês Fonseca Gonçalves; Lukas Weber; Patrick Michael Pilz; Lubos Budinsky; Thomas Helbich; Bruno Karl Podesser
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

7.  Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains.

Authors:  Shiya Liu; Zhiyuan Wang; Daoqi Zhu; Jiabin Yang; Dandan Lou; Ruijiao Gao; Zetai Wang; Aiwu Li; Ying Lv; Qin Fan
Journal:  J Pharm Anal       Date:  2020-12-02

Review 8.  Connecting different heart diseases through intercellular communication.

Authors:  Tania Martins-Marques
Journal:  Biol Open       Date:  2021-09-08       Impact factor: 2.422

9.  Inhibition of Long Noncoding RNA SNHG20 Improves Angiotensin II-Induced Cardiac Fibrosis and Hypertrophy by Regulating the MicroRNA 335/Galectin-3 Axis.

Authors:  Mingyang Li; Chunli Qi; Renxing Song; Chunming Xiong; Xiao Zhong; Ziguang Song; Zhongping Ning; Xiang Song
Journal:  Mol Cell Biol       Date:  2021-08-24       Impact factor: 4.272

Review 10.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.